IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $990,132 | +46.7% | 33,394 | -21.5% | 0.03% | +26.9% |
| Q3 2023 | $674,744 | -12.2% | 42,517 | +4.4% | 0.03% | -7.1% |
| Q2 2023 | $768,367 | +411.7% | 40,719 | +4.1% | 0.03% | +366.7% |
| Q1 2023 | $150,163 | +77303.6% | 39,105 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $194 | -99.9% | 39,105 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $187,000 | +1.1% | 39,105 | -5.0% | 0.01% | 0.0% |
| Q2 2022 | $185,000 | -5.6% | 41,177 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $196,000 | -35.9% | 41,177 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $306,000 | +43.7% | 41,177 | +9.6% | 0.01% | +25.0% |
| Q3 2021 | $213,000 | -14.1% | 37,560 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $248,000 | -14.5% | 37,560 | +4.9% | 0.01% | -18.2% |
| Q1 2021 | $290,000 | +8.6% | 35,811 | -13.4% | 0.01% | 0.0% |
| Q4 2020 | $267,000 | +122.5% | 41,364 | +23.8% | 0.01% | +83.3% |
| Q3 2020 | $120,000 | -22.1% | 33,412 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $154,000 | – | 33,412 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |